IL6 and metabolic dysfunction-associated steatotic liver disease: No significant difference was observed in the levels of IL-6 between the two groups; however, the levels in the STINGgt group were lower than those in the WT group (Figures 3E–G), suggesting that STING deletion inhibited the inflammatory damage in HFD-induced NAFLD.